ProQR Therapeutics segnala gli utili su base trimestrale. Questi report sugli utili trimestrali offrono agli investitori uno sguardo ai risultati finanziari di un'azienda per un periodo di 3 mesi. I report sugli utili includono quasi sempre i risultati EPS e i ricavi.
Analizza lo storico degli utili di ProQR Therapeutics utilizzando ordinamenti e filtri avanzati.
Get Alert | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
PRQR | ProQR Therapeutics | -$0.11 | -$0.10 | — | — | $4.22M | $8.55M | — | — | 11/06/2025 | |
PRQR | ProQR Therapeutics | -$0.03 | -$0.08 | -$0.12 | -50.00% | $6.79M | $8.44M | $4.33M | -48.73% | 08/07/2025 | |
PRQR | ProQR Therapeutics | -$0.10 | -$0.16 | -$0.10 | 34.38% | $4.83M | $4.90M | $4.75M | -3.02% | 05/08/2025 | |
PRQR | ProQR Therapeutics | -$0.08 | -$0.15 | -$0.10 | 33.33% | $3.54M | $6.97M | $4.60M | -34.05% | 03/13/2025 | |
PRQR | ProQR Therapeutics | -$0.08 | -$0.11 | -$0.11 | 0.00% | $1.49M | $12.12M | $4.22M | -65.15% | 11/07/2024 | |
PRQR | ProQR Therapeutics | -$0.11 | -$0.14 | -$0.03 | 78.57% | $1.31M | $12.51M | $6.79M | -45.74% | 08/08/2024 | |
PRQR | ProQR Therapeutics | -$0.12 | -$0.12 | -$0.10 | 18.33% | $702.97K | $3.37M | $4.83M | 43.41% | 05/09/2024 | |
PRQR | ProQR Therapeutics | -$0.16 | — | -$0.08 | — | $839.01K | — | $3.54M | — | 03/13/2024 | |
PRQR | ProQR Therapeutics | -$0.34 | -$0.09 | -$0.08 | 11.11% | $963.77K | $3.59M | $1.49M | -58.47% | 11/07/2023 | |
PRQR | ProQR Therapeutics | -$0.22 | -$0.12 | -$0.11 | 8.33% | $1.09M | $1.35M | $1.31M | -2.74% | 08/03/2023 | |
PRQR | ProQR Therapeutics | -$0.22 | -$0.12 | -$0.12 | 1.67% | $1.39M | $1.42M | $702.97K | -50.49% | 05/16/2023 | |
PRQR | ProQR Therapeutics | -$0.30 | -$0.18 | -$0.16 | 11.11% | $273.37K | $1.02M | $839.01K | -17.74% | 03/29/2023 | |
PRQR | ProQR Therapeutics | -$0.26 | -$0.21 | -$0.34 | -61.90% | $1.03M | — | $963.77K | — | 11/09/2022 | |
PRQR | ProQR Therapeutics | -$0.29 | -$0.22 | -$0.22 | 0.00% | $292.72K | — | $1.09M | — | 08/04/2022 | |
PRQR | ProQR Therapeutics | -$0.30 | -$0.25 | -$0.22 | 12.00% | $170.03K | $590.00K | $1.39M | 134.75% | 05/05/2022 | |
PRQR | ProQR Therapeutics | -$0.31 | -$0.21 | -$0.30 | -42.86% | $314.77K | $450.00K | $273.37K | -39.25% | 02/24/2022 | |
PRQR | ProQR Therapeutics | -$0.30 | -$0.24 | -$0.26 | -8.33% | $293.32K | $280.00K | $1.03M | 267.14% | 11/04/2021 | |
PRQR | ProQR Therapeutics | -$0.09 | -$0.27 | -$0.29 | -7.41% | $9.55M | $290.00K | $292.72K | 0.94% | 08/05/2021 | |
PRQR | ProQR Therapeutics | -$0.35 | -$0.29 | -$0.30 | -3.45% | $290.09K | $570.00K | $170.03K | -70.17% | 05/06/2021 | |
PRQR | ProQR Therapeutics | -$0.43 | — | -$0.31 | — | $470.64K | — | $314.77K | — | 02/25/2021 | |
PRQR | ProQR Therapeutics | -$0.34 | — | -$0.30 | — | $530.00K | — | $293.32K | — | 11/16/2020 |
Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
---|---|---|---|---|
Q2 | 2025-08-07 | $-0.12 | $-0.08 | -50.0 % |
Q1 | 2025-05-08 | $-0.11 | $-0.16 | 34.4 % |
Q4 | 2025-03-13 | $-0.10 | $-0.15 | 33.3 % |
Q3 | 2024-11-07 | $-0.11 | $-0.11 | 0.00 % |
Trimestre fiscale | Data segnalata | Entrate effettive | Entrate stimate | Sorpresa% |
---|---|---|---|---|
Q2 | 2025-08-07 | $4.33M | $8.44M | -48.7 % |
Q1 | 2025-05-08 | $4.75M | $4.90M | -3.02 % |
Q4 | 2025-03-13 | $4.60M | $6.97M | -34.1 % |
Q3 | 2024-11-07 | $4.22M | $12.12M | -65.1 % |
Si prevede che ProQR Therapeutics (PRQR) fornisca risultati il novembre 6, 2025. Gli ultimi risultati sono stati pubblicati il agosto 7, 2025 per il Q2.
L'EPS effettivo era $-0.12, che mancato la stima di $-0.08.
Le entrate effettive sono state $4.3M, che mancato la stima di $8.4M.
Sfoglia stime sugli utili, EPS e ricavi su tutte le azioni.